Medicine & Life Sciences
3-nitrotyrosine
21%
Acute Liver Failure
19%
Anti-Inflammatory Agents
12%
Control Groups
8%
Cyclooxygenase 2 Inhibitors
38%
Cyclooxygenase Inhibitors
79%
Galactosamine
87%
Inbred ICR Mouse
20%
Indomethacin
49%
Injections
9%
Lipopolysaccharides
56%
Liver
34%
Messenger RNA
18%
Necrosis
12%
nimesulide
72%
Pharmaceutical Preparations
6%
Polymerase Chain Reaction
9%
Proteins
6%
Sepsis
13%
Serum
7%
Theoretical Models
53%
Therapeutics
5%
Western Blotting
11%
Wounds and Injuries
32%
Agriculture & Biology
animal models
58%
anti-inflammatory agents
14%
blood
6%
blood serum
8%
cyclooxygenase inhibitors
89%
dosage
5%
galactosamine
82%
hepatotoxicity
13%
indomethacin
36%
inducible nitric oxide synthase
13%
injection
7%
lipopolysaccharides
63%
liver
38%
liver failure
17%
mice
31%
necrosis
9%
pretreatment
8%
prostaglandin synthase
73%
protective effect
10%
reverse transcriptase polymerase chain reaction
8%
thiobarbituric acid-reactive substances
11%
tissues
9%
Western blotting
9%
Chemical Compounds
Anti-Inflammatory Drug
42%
Dose
25%
EC 1.14.99.1 (Prostaglandin-Endoperoxide Synthase) Inhibitor
99%
Lipopolysaccharide
72%
Nimesulide
100%
Nitrotyrosine
52%
Protective
27%
Protein
13%
Reduction
15%